Dynatronics (NASDAQ:DYNT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Monday, Zacks.com reports.

According to Zacks, “DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. “

A number of other brokerages have also weighed in on DYNT. Roth Capital cut their target price on shares of Dynatronics from $4.50 to $4.00 and set a “buy” rating on the stock in a research report on Wednesday, February 13th. TheStreet lowered shares of Dynatronics from a “c-” rating to a “d+” rating in a research report on Wednesday, February 13th. Maxim Group began coverage on shares of Dynatronics in a research report on Thursday, April 4th. They issued a “buy” rating and a $3.75 target price on the stock. Finally, ValuEngine lowered shares of Dynatronics from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $3.67.

Shares of Dynatronics stock opened at $1.73 on Monday. Dynatronics has a fifty-two week low of $1.61 and a fifty-two week high of $3.60. The company has a current ratio of 1.43, a quick ratio of 0.66 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $14.73 million, a price-to-earnings ratio of -4.33 and a beta of -0.19.

Dynatronics (NASDAQ:DYNT) last issued its earnings results on Tuesday, May 14th. The medical equipment provider reported ($0.09) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.09). Dynatronics had a negative net margin of 1.92% and a negative return on equity of 12.65%. The firm had revenue of $14.55 million for the quarter, compared to analyst estimates of $14.64 million. Equities analysts anticipate that Dynatronics will post -0.19 EPS for the current fiscal year.

An institutional investor recently bought a new position in Dynatronics stock. Vanguard Group Inc purchased a new stake in shares of Dynatronics Co. (NASDAQ:DYNT) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 27,747 shares of the medical equipment provider’s stock, valued at approximately $79,000. Vanguard Group Inc owned about 0.34% of Dynatronics as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 13.19% of the company’s stock.

Dynatronics Company Profile

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.

Further Reading: How Important is Technical Analysis of Stocks

Get a free copy of the Zacks research report on Dynatronics (DYNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.